Dynamic Arterial Lactate Values Are Associated with 30-Day Mortality in Patients with Acute Myocardial Infarction and Cardiogenic Shock on Intra-Aortic Balloon Pump Circulatory Support

The study conducted by Dr. Aurelia Georgeta Solomonean and colleagues [1] investigates the prognostic role of dynamic arterial lactate levels in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) treated with intra-aortic balloon pump (IABP) support. Through this retrospective analysis, the authors evaluate lactate kinetics as a predictive marker for 30-day mortality, offering novel insights into its application in risk stratification and therapeutic decision-making.This work highlights the significance of lactate trends, emphasizing that while baseline lactate levels provide an initial assessment, the changes observed within the first 24 h of IABP therapy yield superior prognostic accuracy. The inclusion of dynamic lactate measurements represents an important step forward in the management of AMI-CS, particularly given the persistent challenges associated with this high-risk condition. The study demonstrates that elevated arterial lactate levels at both baseline and after 24 h are strongly associated with increased 30-day mortality. Moreover, the authors propose that integrating lactate clearance as a parameter may guide escalation of care, supporting a more tailored approach to mechanical circulatory support.Despite advances in revascularization techniques and supportive therapies, cardiogenic shock continues to be associated with poor outcomes, with mortality rates remaining alarmingly high. Previous studies, such as the IABP-SHOCK II trial [2], have questioned the efficacy of IABP in reducing mortality; however, this study underscores the potential utility of IABP in conjunction with close monitoring of metabolic markers like lactate. Recent investigations into lactate metabolism [3, 4] have further elucidated its role as a dynamic indicator of tissue perfusion and metabolic stress. The current findings build on this foundation, aligning with evidence from Schrage et al. [5] regarding the evolving landscape of mechanical circulatory support in cardiogenic shock.This study’s contributions lie not only in its methodological rigor but also in its clinical implications. The detailed analysis of lactate kinetics provides a framework for identifying patients at heightened risk, enabling timely intervention. The authors address key limitations of prior research by incorporating multivariable adjustments for baseline risk factors, including organ damage markers such as creatinine. Additionally, they provide valuable insights into the importance of therapeutic adjustments, particularly regarding vasoactive agents and anticoagulation protocols, in optimizing patient outcomes. Levy et al. [6] have previously emphasized the metabolic dimension of shock states, and this study reinforces the centrality of lactate monitoring within this paradigm. Furthermore, the multidisciplinary guidance outlined by Mebazaa et al. [7] complements the findings by advocating for integrated care strategies in managing acute heart failure and cardiogenic shock.In conclusion, this study advances our understanding of the prognostic role of dynamic lactate values in AMI-CS patients receiving IABP therapy. By demonstrating the predictive power of lactate trends over static measurements, the authors provide a compelling argument for incorporating these parameters into routine clinical practice. While further prospective studies are warranted to validate these findings and refine therapeutic algorithms, the work by Solomonean et al. [1] represents a significant contribution to the ongoing efforts to improve outcomes in cardiogenic shock.The authors thank Dr. Aurelia Georgeta Solomonean and colleagues for they research.The authors have no conflicts of interest to declare.The authors have not received any financial support.J.L.P.: conceptualization, validation, writing – original draft, and writing – review and editing; V.J.R., M.L.P., G.G.L., and L.M.L.B. validation and writing – review and editing.